J&J’s consumer division Kenvue floats $41bn IPO
Johnson & Johnson consumer arm Kenvue floats biggest US IPO since 2021. Kenvue is valued at $41bn after being divisioned off from US.
Drugs
Health
Pharma
Johnson & Johnson consumer arm Kenvue floats biggest US IPO since 2021. Kenvue is valued at $41bn after being divisioned off from US.